Osteogenic Articles & Analysis
3 news found
“We are excited to announce that i-FACTOR+ Matrix is now fully available in Canada through our distributor Surgi-One and can be used in both spine and general orthopedic applications,” said Glen Kashuba, Chief Executive Officer of Cerapedics, “Canada will be the first market offering the i-FACTOR+ MATRIX product, which leverages the clinically proven P-15 ...
It has been shown that nano-scale surface topographies generate osteogenic responses that drive bone growth required for a solid fusion. ...
“We are excited to announce Canadian regulatory approval of our next-generation product, based on P15 osteogenic cell-binding peptide , i-FACTOR+ Matrix,” said Glen Kashuba, Chief Executive Officer of Cerapedics, “The matrix product leverages the clinically proven power of the P15 peptide combined with a collagen carrier for optimized interoperative ...